GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Nelonemdaz (Neu2000) is under development for the treatment of acute ischemic stroke, traumatic brain injury, traumatic spinal cord injury and burn injury, cerebral infarction. It is administered ...
ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse)ACCORD-2 Phase 3 ...
US CNS specialist Axsome Therapeutics yesterday announced the completion of its Phase III clinical program evaluating AXS-05 ...
New Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...
Shares of Axsome Therapeutics (AXSM) are under pressure on Monday after the company reported mixed results for a pair of studies of its ...
CNET on MSN4h
Sub Your Melatonin Supplements for Magnesium. Here Are the Best Types of Magnesium for SleepMagnesium supplementation can calm your nervous system, relax your muscles and improve your sleep quality. Here's why it ...
Researchers have discovered that aspartate plays a key role in making the lungs a common site for cancer metastasis.
In one study, the company’s drug eased the agitation for Alzheimer’s patients. In a different study, there wasn’t a ...
More than half of cancer patients in whom the cancer spreads beyond the primary site have lung metastases. What makes the ...
IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine ...
Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback